Literature DB >> 21644054

PARP1 and CASP3 gene expression in a patient with multiple head and neck squamous cell carcinoma and Parkinson disease.

Aldo E Calogero, Pier Franco Soma, Maria C Giuffrida, Domenica Giuffrida, Sandro La Vignera, Carmelo Romano, Roberto Castiglione, Paolo Bosco, Michele Salemi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21644054     DOI: 10.1007/s13577-011-0021-4

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


× No keyword cloud information.
  9 in total

Review 1.  The biochemistry of apoptosis.

Authors:  M O Hengartner
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

2.  Poly(ADP-ribose) (PAR) polymer is a death signal.

Authors:  Shaida A Andrabi; No Soo Kim; Seong-Woon Yu; Hongmin Wang; David W Koh; Masayuki Sasaki; Judith A Klaus; Takashi Otsuka; Zhizheng Zhang; Raymond C Koehler; Patricia D Hurn; Guy G Poirier; Valina L Dawson; Ted M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

3.  Expression of SpanX mRNA in testicular germ cell tumors.

Authors:  Michele Salemi; Aldo E Calogero; Paolo Bosco; Roberto Castiglione; Sandro La Vignera; Eugenia Borgione; Giancarlo Rappazzo; Enzo Vicari
Journal:  Hum Cell       Date:  2006-08       Impact factor: 4.174

Review 4.  The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus.

Authors:  C C R Ragin; F Modugno; S M Gollin
Journal:  J Dent Res       Date:  2007-02       Impact factor: 6.116

Review 5.  Epidemiology of Parkinson's disease.

Authors:  Guido Alves; Elin Bjelland Forsaa; Kenn Freddy Pedersen; Michaela Dreetz Gjerstad; Jan Petter Larsen
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

Review 6.  Caspases: killer proteases.

Authors:  D W Nicholson; N A Thornberry
Journal:  Trends Biochem Sci       Date:  1997-08       Impact factor: 13.807

7.  Gene disruption of caspase-3 prevents MPTP-induced Parkinson's disease in mice.

Authors:  Marina Yamada; Kotaro Kida; Willington Amutuhaire; Fumito Ichinose; Masao Kaneki
Journal:  Biochem Biophys Res Commun       Date:  2010-10-19       Impact factor: 3.575

8.  Anticonvulsant effects of carbenoxolone in genetically epilepsy prone rats (GEPRs).

Authors:  Pietro Gareri; Daniele Condorelli; Natale Belluardo; Emilio Russo; Antonella Loiacono; Vincenza Barresi; Angela Trovato-Salinaro; Angela Trovato-Salinato; Melita B Mirone; Guido Ferreri Ibbadu; Giovambattista De Sarro
Journal:  Neuropharmacology       Date:  2004-12       Impact factor: 5.250

9.  Head and neck cancer radiosensitization by the novel poly(ADP-ribose) polymerase inhibitor GPI-15427.

Authors:  Khurram Khan; Koji Araki; Daiyou Wang; Guayan Li; Xin Li; Jie Zhang; Weizheng Xu; Randall K Hoover; Susan Lauter; Bert O'Malley; Rena G Lapidus; Daqing Li
Journal:  Head Neck       Date:  2010-03       Impact factor: 3.147

  9 in total
  4 in total

1.  PARP-1 and CASP3 genes are up-regulated in LNCaP and PC-3 prostate cancer cell lines.

Authors:  Michele Salemi; Rosita A Condorelli; Sandro La Vignera; Nunziata Barone; Federico Ridolfo; Maria C Giuffrida; Enzo Vicari; Aldo E Calogero
Journal:  Hum Cell       Date:  2014-07-19       Impact factor: 4.174

2.  Expression of STRBP mRNA in patients with cryptorchidism and Down's syndrome.

Authors:  M Salemi; S La Vignera; R Castiglione; R A Condorelli; L Cimino; P Bosco; C Romano; C Romano; A E Calogero
Journal:  J Endocrinol Invest       Date:  2012-01       Impact factor: 4.256

3.  PARP-1 protein expression in glioblastoma multiforme.

Authors:  A Galia; A E Calogero; R Condorelli; F Fraggetta; A La Corte; F Ridolfo; P Bosco; R Castiglione; M Salemi
Journal:  Eur J Histochem       Date:  2012-02-27       Impact factor: 3.188

4.  Gene expression profiling analysis contributes to understanding the association between non-syndromic cleft lip and palate, and cancer.

Authors:  Hongyi Wang; Tao Qiu; Jie Shi; Jiulong Liang; Yang Wang; Liangliang Quan; Yu Zhang; Qian Zhang; Kai Tao
Journal:  Mol Med Rep       Date:  2016-01-20       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.